• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多中心临床经验:应用非侵入性游离细胞 DNA 筛查 X 单体和相关 X 染色体变异。

Multicenter clinical experience with non-invasive cell-free DNA screening for monosomy X and related X-chromosome variants.

机构信息

Department of Prenatal Medicine and Fetal Therapy, Justus-Liebig University, Giessen, Germany.

Prenatal Medicine and Genetics München, Duesseldorf, Germany.

出版信息

Prenat Diagn. 2023 Feb;43(2):192-206. doi: 10.1002/pd.6320. Epub 2023 Feb 9.

DOI:10.1002/pd.6320
PMID:36726284
Abstract

OBJECTIVE

We aimed to investigate how the presence of fetal anomalies and different X chromosome variants influences Cell-free DNA (cfDNA) screening results for monosomy X.

METHODS

From a multicenter retrospective survey on 673 pregnancies with prenatally suspected or confirmed Turner syndrome, we analyzed the subgroup for which prenatal cfDNA screening and karyotype results were available. A cfDNA screening result was defined as true positive (TP) when confirmatory testing showed 45,X or an X-chromosome variant.

RESULTS

We had cfDNA results, karyotype, and phenotype data for 55 pregnancies. cfDNA results were high risk for monosomy X in 48/55, of which 23 were TP and 25 were false positive (FP). 32/48 high-risk cfDNA cases did not show fetal anomalies. Of these, 7 were TP. All were X-chromosome variants. All 16 fetuses with high-risk cfDNA result and ultrasound anomalies were TP. Of fetuses with abnormalities, those with 45,X more often had fetal hydrops/cystic hygroma, whereas those with "variant" karyotypes had different anomalies.

CONCLUSION

Both, 45,X or X-chromosome variants can be detected after a high-risk cfDNA result for monosomy X. When there are fetal anomalies, the result is more likely a TP. In the absence of fetal anomalies, it is most often an FP or X-chromosome variant.

摘要

目的

本研究旨在探讨胎儿异常和不同 X 染色体变异体的存在如何影响 X 单体型无创产前 DNA 筛查结果。

方法

本研究对 673 例产前疑似或确诊特纳综合征的孕妇进行了多中心回顾性调查,分析了其中具有产前 cfDNA 筛查和核型结果的亚组。当确认性检测显示 45,X 或 X 染色体变异体时,cfDNA 筛查结果被定义为真阳性(TP)。

结果

我们共纳入了 55 例具有 cfDNA 结果、核型和表型数据的妊娠。在 55 例妊娠中,cfDNA 结果显示 X 单体型高风险的有 48 例,其中 23 例为 TP,25 例为假阳性(FP)。在 48 例高风险 cfDNA 病例中,32 例未显示胎儿异常。其中,7 例为 TP,均为 X 染色体变异体。所有高风险 cfDNA 结果且超声异常的胎儿均为 TP。在存在异常的胎儿中,45,X 型更常伴有胎儿水肿/囊状水瘤,而“变异”核型则具有不同的异常。

结论

在 X 单体型高风险 cfDNA 结果后,均可检测到 45,X 或 X 染色体变异体。当存在胎儿异常时,结果更可能为 TP。在不存在胎儿异常的情况下,通常为 FP 或 X 染色体变异体。

相似文献

1
Multicenter clinical experience with non-invasive cell-free DNA screening for monosomy X and related X-chromosome variants.多中心临床经验:应用非侵入性游离细胞 DNA 筛查 X 单体和相关 X 染色体变异。
Prenat Diagn. 2023 Feb;43(2):192-206. doi: 10.1002/pd.6320. Epub 2023 Feb 9.
2
Cell-free DNA screening positive for monosomy X: clinical evaluation and management of suspected maternal or fetal Turner syndrome.游离胎儿 DNA 筛查结果提示 X 单体:疑似母源性或胎儿特纳综合征的临床评估与管理。
Am J Obstet Gynecol. 2022 Dec;227(6):862-870. doi: 10.1016/j.ajog.2022.07.004. Epub 2022 Jul 13.
3
Discordance between ultrasound and cell free DNA screening for monosomy X.超声检查与游离DNA筛查X单体性之间的不一致性。
Arch Gynecol Obstet. 2016 Aug;294(2):219-24. doi: 10.1007/s00404-016-4077-y. Epub 2016 Mar 29.
4
Analysis of cell-free DNA in maternal blood in screening for aneuploidies: updated meta-analysis.母体血液游离 DNA 分析在非整倍体筛查中的应用:更新的荟萃分析。
Ultrasound Obstet Gynecol. 2017 Sep;50(3):302-314. doi: 10.1002/uog.17484. Epub 2017 Jul 27.
5
Positive predictive value estimates for cell-free noninvasive prenatal screening from data of a large referral genetic diagnostic laboratory.基于大型转诊基因诊断实验室数据的无细胞非侵入性产前筛查的阳性预测值估计
Am J Obstet Gynecol. 2017 Dec;217(6):691.e1-691.e6. doi: 10.1016/j.ajog.2017.10.005. Epub 2017 Oct 13.
6
State-wide utilization and performance of traditional and cell-free DNA-based prenatal testing pathways: the Victorian Perinatal Record Linkage (PeRL) study.全州范围内传统和无细胞 DNA 产前检测途径的利用和表现:维多利亚州围产期记录链接(PeRL)研究。
Ultrasound Obstet Gynecol. 2020 Aug;56(2):215-224. doi: 10.1002/uog.21899.
7
Should cell-free DNA testing be used in pregnancy with increased fetal nuchal translucency?在胎儿颈项透明层增厚的妊娠中是否应该使用游离 DNA 检测?
Ultrasound Obstet Gynecol. 2020 May;55(5):645-651. doi: 10.1002/uog.20397. Epub 2020 Apr 7.
8
Multiple marker screening test: identification of fetal cystic hygroma, hydrops, and sex chromosome aneuploidy.多项标志物筛查试验:胎儿颈部水囊瘤、水肿及性染色体非整倍体的识别
J Matern Fetal Med. 1996 Jan-Feb;5(1):31-5. doi: 10.1002/(SICI)1520-6661(199601/02)5:1<31::AID-MFM7>3.0.CO;2-U.
9
Clinical implementation of routine screening for fetal trisomies in the UK NHS: cell-free DNA test contingent on results from first-trimester combined test.英国国民医疗服务体系(NHS)中胎儿三体综合征常规筛查的临床实施:基于孕早期联合检测结果的游离DNA检测
Ultrasound Obstet Gynecol. 2016 Jan;47(1):45-52. doi: 10.1002/uog.15783. Epub 2015 Oct 26.
10
Contingent first-trimester screening for aneuploidies with cell-free DNA in a Danish clinical setting.在丹麦临床环境中使用游离胎儿 DNA 进行有条件的早孕期筛查非整倍体。
Ultrasound Obstet Gynecol. 2018 Apr;51(4):470-479. doi: 10.1002/uog.17562. Epub 2018 Mar 4.

引用本文的文献

1
Clinical practice guidelines for the care of girls and women with Turner syndrome.特纳综合征患者的护理临床实践指南。
Eur J Endocrinol. 2024 Jun 5;190(6):G53-G151. doi: 10.1093/ejendo/lvae050.
2
Unique Challenges of NIPT for Sex Chromosome Aneuploidy.无创性产前检测(NIPT)用于性染色体非整倍体的独特挑战。
Clin Obstet Gynecol. 2023 Sep 1;66(3):568-578. doi: 10.1097/GRF.0000000000000804. Epub 2023 Jul 24.